Abstract: When using multiple targets and libraries, selection of affinity reagents from phage-displayed libraries is a relatively time-consuming process. Herein, we describe an automation-amenable approach to accelerate the process by using alkaline phosphatase (AP) fusion proteins in place of the phage ELISA screening and subsequent confirmation steps with purified protein. After two or three rounds of affinity selection, the open reading frames that encode the affinity selected molecules (i.e., antibody fragments, engineered scaffold proteins, combinatorial peptides) are amplified from the phage or phagemid DNA molecules by PCR and cloned en masse by a Ligation Independent Cloning (LIC) method into a plasmid encoding a highly active variant of E. coli AP. This time-saving process identifies affinity reagents that work out of context of the phage and that can be used in various downstream enzyme linked binding assays. The utility of this approach was demonstrated by analyzing single-chain antibodies (scFvs), engineered fibronectin type III domains (FN3), and combinatorial peptides that were selected for binding to the Epsin Nterminal Homology (ENTH) domain of epsin 1, the c-Src SH3 domain, and the appendage domain of the gamma subunit of the clathrin adaptor complex, AP-1, respectively.
INTRODUCTION
With the recent sequencing of multiple bacterial and eukaryotic genomes, the scientific community's attention is now directed at determining the function of the thousands of proteins encoded by each cell. A critical resource for probing cells to learn when a protein is synthesized, where it is localized, and what it is associated with in the cell, is an affinity reagent for said protein. However, it typically takes several months to generate polyclonal or monoclonal antibodies or identify peptide ligands for any given target protein. To overcome the time limitations for generating affinity reagents to thousands of protein targets in a proteome, high-throughput molecular biology and biochemical techniques are necessary. One such method for generating affinity reagents is phage-display, in which bacteriophage particles are engineered to display antibody fragments, engineered proteins, or peptides on their surface [1] [2] [3] [4] . By affinity selection, it is possible to isolate antibodies that recognize protein targets with great selectivity and affinity [3, 5] from phage libraries displaying single chain fragments of variable regions (scFv) of antibodies or fragments of antigen binding (Fab) of antibodies. Engineered protein scaffolds, such as lipocalin [6] , the tenth type III domain of human fibronectin (FN3) [7] , natural and artificial helix bundles [8, 9] and CTLA-4 *Address correspondence to this author at the Combinatorial Biology Unit, Biosciences Division, Argonne National Laboratory, 9700 South Cass Avenue, Argonne, IL 60439 USA; Tel: (630) 252-3824; Fax: (630) 214-0648; E-mail: bkay@anl.gov [10] appear to be promising sources of alternative affinity reagents. Lastly, combinatorial peptides, which are displayed on phage, have been exploited to discover peptide ligands with biological significance [11, 12] .
A major rate-limiting step in a typical phage-display experiment is that after two or more rounds of affinity selection, individual phage clones need to be prepared and evaluated via an enzyme linked immunosorbent assay (ELISA) to discover the binding clones [13] . Once phage have been confirmed to bind and their insert sequenced, the individual protein (or peptide) sequences are chosen for further evaluation as soluble [14] , biotinylated [15] , or enzyme-linked fusion [16] proteins or peptides. In an attempt to streamline the lengthy process of identifying useful affinity reagents from a phage-displayed library, we have constructed an expression vector that permits efficient transfer of DNA fragments from phage or phagemid vectors and yields an alkaline phosphatase (AP) fusion protein to the affinity reagents. It has been shown that many different peptides [16] [17] [18] , protein domains [16] , and scFvs [19] [20] [21] [22] [23] still retain their binding activity after fusion to the Nterminus of the mature form of AP, making these fusion proteins valuable probes of protein function and location. Herein, we describe the application of this vector to screen three different kinds of phage-displayed molecules (i.e., scFv, engineered scaffold, combinatorial peptide) for binding to the Epsin N-terminal Homology (ENTH) domain [24] of rat epsin 1 [25] , the c-Src Homology 3 (SH3) domain, and the appendage domain of the gamma subunit of the adaptor complex, AP-1 [26] . Application of the AP fusion proteins saves several days of experimental work, and identifies those affinity reagents that work effectively as enzyme fusion proteins.
MATERIALS AND METHODS

Bacterial Strains, Plasmids and Chemicals
All restriction endonucleases and DNA modifying enzymes, including T4 DNA ligase and polymerase, were obtained from New England BioLabs (Beverly, MA). Pfu Turbo DNA Polymerase was from Stratagene (La Jolla, CA). pET20b(+) and E. coli BL21 (DE3) were from Novagen (Madison, WI). The pAK100HP151 plasmid, encoding E. coli alkaline phosphatase fused to an scFv recognizing the six histidine tag and the chloramphenicol resistance (Cm r ) marker, was a gift of Dr. Andreas Plückthun (University of Zürich, Switzerland). A single domain fragment of the variable region of a camel heavy chain (VHH) antibody, which recognizes hen lysozyme [27] , was obtained from Dr. Serge Mulydermanns (Vrije Universiteit, Belgium). Other single-chain antibodies were selected from a phage-displayed scFvs library [28] . Glutathione-S-transferase (GST) fusion proteins were prepared as described [29, 30] . His-tagged APC 1520 protein was a gift from the Structural Biology Center of Argonne National Laboratory. All other chemicals were of analytical reagent grade.
DNA Manipulations
All vectors were constructed from pET20b(+) as the parent vector. Briefly, a fragment containing an LIC site and BamH I/Kpn I/EcoR I sites was cloned into the Nco I/Xho I sites of pET20b(+) with four annealed oligonucleotides (F1: 5'-catggtggcggccgcccccgggagcggcagcggcagta-3'; R1: 5'-agcttactggcgctgccgctcccgggggcggccgccac-3'; F2: 5'-agcttgagaacctgtacttccaatcctcggatccggtaccggggaattcgc-3'; R2: 5'-tcgagcgaattccccggtaccggatccgaggattggaagtacaggttctca-3'). The Pvu II site in the resulting recombinant was used to insert the chloramphenicol (Cm r ) resistance marker, which was amplified from pAK100HP151 by the polymerase chain reaction (PCR). The intermediate construct, pEZ704 expressing wild type AP was generated by PCR amplification of the AP coding region of pAK100HP151, and incorporation into BamH I and Kpn I restriction sites of the recombinant plasmid with an LIC site, and Cm r and ampicillin (Amp r ) resistance markers. The final vector construct, pEZ707, includes a double mutant (D153G/D330N) of AP, which was created by site-directed PCR mutagenesis [30] . AP proteins were induced in E. coli BL21(DE3) cells with isopropyl-β-D-thiogalactopyranoside (IPTG). The expressed proteins, which possess a six histidine tag at their C-termini, were purified by immobilized metal affinity chromatography (IMAC), as described by the resin manufacturer (Qiagen, Valencia, CA), and profiled for quantity, molecular weight and purity with a BioAnalyzer 2100 (Agilent, Palo Alto, CA).
Open reading frames encoding various affinity reagents were cloned into pEZ707 by LIC [31] . Briefly, pEZ707 was linearized with S m a I, and incubated with T4 DNA polymerase and dATP to generate 17 nucleotide long "sticky ends". The DNA inserts, encoding the affinity reagents, were amplified by PCR with oligonucleotide primers that generate complementary sticky ends after incubation with T4 DNA polymerase and dTTP. The primers for amplification of scFvs were prepared based on known or degenerate sequences for library construction [28] . Oligonucleotide primers were used for PCR amplification of output of the FN3 (5'-tggtggcggccgcccccgtttctgatgttccgcgtaagc-3', 5'-ctgccgctgccgctccctacggtagttaatcgag-3') and combinatorial peptide (5'-tggtggcggccgcccccgtggtaccttctattctcactcg-3', 5'-ctgccgctgccgctcccctaaacaactttcaacagtttcg-3') libraries. The treated inserts and vector DNA were incubated together at 55 o C for five minutes, cooled to room temperature over 20 minutes, and introduced into E. coli BL21(DE3) via electroporation. Transformed E. coli were selected on Petri plates containing ampicillin (100 microgram/ml) and chloramphenicol (20 microgram/ml), and recombinant plasmids were confirmed by DNA sequencing.
Affinity Selection of Phage and ELISAs
Protocols for the affinity selection and phage ELISA were conducted as described by Kay et al. [13] . A GST fusion to the N-terminal EH domain of Xenopus laevis intersectin [32] was used to affinity select an scFv from a human naïve scFv library [33] . A GST fusion to the c-Src SH3 domain was selected from another human naïve scFv library [28] . The same fusion was used affinity select binders from a library of 2 x 10 9 different FN3 molecules in which five amino acids in loops BC and FG were each randomized with NNK codons (Karatan et al., in preparation). The phage-displayed combinatorial peptide library, X 10 , in which X is any amino acid encoded by NNK codons, was constructed according to a published protocol [34] and screened with the appendage domain of the gamma subunit of AP-1.
The assay for detection of antigen binding by scFvs with AP fusions was conducted by picking colonies into 96 deep well microtiter plates (Whatman, Clifton, NJ), containing 0.5 ml of Luria Broth (LB) supplemented with ampicillin in each well, and incubating them at 37 o C with shaking at 250 rpm. When the optical density (OD 600nm ) of the wells reached a value of 0.5, IPTG was added to a final concentration of 0.5 mM, and the cultures were incubated at 30 o C overnight with continuous shaking. Next, the cells were collected by centrifugation, the media was discarded, and pellets were resuspended in 0.2 ml BugBuster TM reagent (Novagen, Madison, WI) to lyse the cells and release the AP fusion proteins. For the enzyme-linked binding assays (ELBA), 20 microliters of cell lysate were mixed with 80 µl of phosphate buffered saline (PBS;137 mM NaCl, 3 mM KCl, 8 mM Na 2 HPO 4 1.5 mM KH 2 PO 4 ) and transferred to microtiter plate wells coated with 200 nanograms of target protein and blocked with 1% bovine serum albumin (BSA). After 2 hours incubation at room temperature, plates were washed four times with PBS supplemented with 0.05% Tween 20 (PBST). The quantity of the AP fusion protein retained in the microtiter plate wells was measured by adding para-nitrophenyl phosphate (pNPP) to the wells and measuring their OD 405nm values after 30 minutes.
Western Blot
Five hundred nanograms of each protein was resolved by SDS-PAGE, and transferred onto a nitrocellulose membrane by electroblotting. The membrane was incubated in blocking (1) . Plasmid map (A) and cloning site (B) of the pEZ707 vector. pEZ707 was constructed based on pET20b(+) by incorporating double-stranded DNA encoding a LIC site (underlined), and sequential insertion of a gene fragment for E. coli alkaline phosphatase mutant (italics). Coding fragments for the affinity molecules were cloned into the vector by LIC to generate AP fusion proteins that are driven by the T7 RNA polymerase promoter, and directed into the periplasm by the pelB signal peptide. The C-terminal six histidine tag is used for purification by IMAC.
buffer (10% fat free dry milk in PBS) for 2 hours at room temperature, and then incubated for one hour at room temperature with crude cell lysates that contained the scFv-AP fusion proteins. After the membrane was washed with PBST, 5-bromo-4-chloro-3-indolyl phosphate (BCIP) was used as a substrate to visualize the blotted proteins bound to the scFv-AP fusion protein.
RESULTS AND DISCUSSION
Construction and Evaluation of the AP Fusion Vector
A plasmid vector (Fig. 1) for the rapid generation of alkaline phosphatase (AP) fusions with the output of a phage-display affinity selection experiment was constructed in several consecutive steps. First, a DNA fragment which contains a LIC site and Sma I/BamH I/Kpn I/EcoR I recognition sites was cloned between the Nco I and Xho I sites of pET20b(+) vector, which encodes the pelB signal sequence and a six histidine C-terminal tag. Second, in order to increase efficiency of transferring DNA fragments from phagemids that carry Amp r , a gene fragment encoding Cm r was cloned into the Pvu II site, to eliminate rescue of contaminating phagemid vector DNA. The resulting plasmid, pEZ701, was used to accept the coding regions of either wild-type or mutant (D153G, D330N) AP. Bacteria carrying either construct accumulates wild-type (pEZ704) or mutant (pEZ707) AP in the periplasm of E. coli BL21(DE3) upon induction with IPTG. The C-terminal six histidine tag permits purification by IMAC, and as seen in Figure 2 , the double-point mutant form of AP has ~16-fold higher specific activity than the wild-type protein, in agreement with published results [35] .
To confirm that the pEZ707 vector is effective in acceptance of DNA fragments to generate AP fusion proteins, we tested the system with four different characterized antibody fragments. The four antibodies consisted of two scFvs selected from naïve libraries [28, 33] that bind to the SH3 domain of human c-Src and the Nterminal EH domain of frog intersectin [32] , the variable domain of a camel heavy chain (VHH) antibody that recognizes hen lysozyme [27] , and an scFv that recognizes six-histidine tags [20] . (Note that the anti-six histidine tag scFv was cloned into a related vector encoding AP without a C-terminal six-histidine tag.) To generate the four recombinant constructs, primers for antibody gene fragments were designed containing LIC sequences (forward: 5'-tggtggcggccgcccc-3'; reverse: 5'-ctgccgctgccgctccc-3') and 18-21 nucleotides annealing with the antibody gene fragments (based on available sequence data). Antibody coding fragments were amplified from the phagemid DNA Fig. (2) . Comparison of wild-type and mutant AP. Gene fragments encoding wild-type (wt) and mutant (mut) AP were cloned into pEZ701 and expressed in E. coli. The expressed AP proteins were purified from a periplasmic extract by IMAC to 95% purity (arrow) and resolved by SDS-PAGE (right panel) along with molecular weight markers (lane M). To compare the mutant and wild-type enzymes, equal amounts of the purified proteins were serially diluted (starting from 1 mg/ml) and enzyme activity was estimated by checking OD 405 after parallel incubation with pNPP, a chromogenic substrate for AP. The results indicate that the mutant enzyme is ~16 times more active than the wild-type form. The values shown are averages of triplicate experiments.
by PCR, purified to remove dNTP and primers, and treated with T4 DNA polymerase in the presence of dTTP to generate 17 nucleotide long sticky-ends. In parallel, the pEZ707 vector DNA was linearized with Sma I and treated with T4 DNA polymerase and dATP to generate complementary termini. The PCR products and vector were annealed and electroporated into E. coli BL21(DE3). Transformed E. coli cells were selected on LB Petri plates containing ampicillin and chloramphenicol, and recombinant constructs were identified by colony PCR and DNA sequencing. PCR analysis of 25 bacterial transformants randomly chosen from the four subcloning experiments (Fig.  3a) revealed that the cloning efficiencies ranged from 92% (23/25) to 100% (25/25) . The colonies with recombinant plasmids exhibited comparable levels of AP activity (Fig.  3b) and demonstrated antigen binding (Fig. 3c) . When each fusion protein was tested in microtiter plate wells coated with the various target and control proteins, only the wells containing the cognate target yielded positive signals (Fig.  4) .
Development of a Protocol to Process Phage-display Output
Based on the above results, we proposed a protocol to accelerate the discovery of affinity reagents by employing AP fusions. The protocol has the potential to save time during affinity reagent development, provide a sensitive detection method for monitoring protein-protein interactions, and identify those sequences that express at high level in E. coli as AP fusion proteins. This concept was further tested with three different combinations of phage-displayed libraries and protein targets: a human scFv library [28] affinity selected against a GST fusion to the ENTH domain of human enthoprotin [26] , an engineered FN3-repeat library affinity selected against the c-Src SH3 domain (Karatan et al., in preparation), and combinatorial peptides selected for binding to the appendage domain of the gamma subunit of the clathrin adaptor AP-1 [36] (Scholle, Jezuit, McPherson, and Kay, unpublished).
PCR was used to amplify and transfer into pEZ707 the coding regions from scFv-displaying phage recovered after two rounds of selection for binding to a GST fusion to the ENTH domain of human enthoprotin. To amplify the coding regions, degenerate oligonucleotide primers were prepared based on sequences used for constructing the scFv library [28] , and fragments cloned by LIC into pEZ707. Colonies were transferred to individual wells of a 96 well microtiter plate, grown overnight with IPTG present, and lysed with BugBuster™ reagent. Since the BugBuster™ detergent used to lyse the bacterial cells had no negative effect on the enzymatic activity of the AP fusions or target binding (data not shown), equivalent volumes of each lysate were added to microtiter plate wells that had been coated with the target proteins used for affinity selection. Retention of the AP fusion proteins in the wells was demonstrated post-washing The open reading frames for four different antibodies were amplified by PCR, and cloned into pEZ707 by the LIC method. Twenty-five bacterial transformants were screened by colony PCR, 92% to 100% of the analyzed colonies deemed recombinant (Panel A.). Twentyfour of the bacterial colonies containing the AP fusion to scFv against the ENTH domain were inoculated in LB medium, and the overnight culture was lysed with detergent. All 24 of the recombinants expressed equivalent level of AP activity (Panel B.), and bound to the microtiter plate wells immobilized with target protein (+), but not to the wells without (-) (Panel C.). Fig. (4) . Selectivity of AP fusion proteins. Gene fragments encoding several antibodies with defined specificity were cloned by LIC into pEZ707 to create fusions with the mutant AP. The fusions were expressed in BL21(DE3), and bacteria were lysed with detergent. The debris was removed by centrifugation, and the supernatant was directly used for a binding assay. All the antibody-AP fusions were subjected for binding assay to an array of different target proteins. The values (OD 405nm ) shown are averages of triplicate experiments. Fig. (5) . Screening of scFvs selected by phage display for binding to human ENTH domain as AP fusion proteins. A naïve scFv library was affinity selected against GST-ENTH domain of human enthoprotin [26] . After two rounds of selection, the gene fragments encoding the selected scFvs were moved en masse into pEZ707 to create scFv-AP fusions. The annealed mixtures were transformed into BL21(DE3) bacteria, and 96 individual colonies were grown overnight with LB in a 96 deep well microtiter plate. The expressed scFv-AP fusions were released from the cells with BugBuster™, and used as a one-step reagent for enzyme-linked binding assay (ELBA). Panel A shows that all the colonies expressed AP activity, and Panel B identifies those clones binding with target protein. by incubation with pNPP. To identify clones that bind BSA or plastic, the samples were checked in parallel with plates coated without the corresponding target (data not shown). Figure 5 demonstrates that scFv-AP fusion proteins could be identified from a phage screen that bind selectively to the GST fusion to the ENTH domain of human enthoprotin. In order to test whether the outcome with the AP fusion proteins was biased compared to the phage screen, a standard phage ELISA was carried out with a similar number of clones chosen at random. The results shown in Table I indicate that the percentage of positives, as measured by standard techniques, is similar to that observed by an enzyme-linked binding assay (ELBA). The protocol was further evaluated for screening of output from the FN3 library and a combinatorial peptide library, following the procedures described above. As shown in Table I , comparison of phage ELISA and AP ELBA supports the conclusion that the output of phage-display selection experiments can be efficiently screened without bias by converting the recovered clones into AP fusion proteins. The correspondence between the ELISA and ELBA screening results agrees with that reported elsewhere for one scFv [23] , although it is anticipated that when certain protein fusions interfere with proper AP folding or activity the ELBA and ELISA results will differ.
A downstream benefit from this protocol is that once binding clones are isolated, the enzyme-linked affinity reagents are ready for additional applications, such as ELBA, competition assays [16] , immunohistochemistry [37] , and Western blotting [38] . In addition, the AP fusion proteins can reveal relative differences in binding that are not obvious from phage ELISA results (Karatan et al., in preparation), even though E. coli AP is a homodimer. (It should be noted that a monomeric form of AP has recently been generated through mutations at the dimer interface [39] , and could be adapted to this protocol, if needed.) As an example of the benefits of using AP fusion proteins, we examined the specificity of two scFv-AP fusion constructs, which were isolated from a phage screen with the enthoprotin ENTH domain, by ELBA and Western blotting. While ELBA data demonstrate that both of the selected scFv molecules bind to the human enthoprotin ENTH domain (Fig. 6) , they likely recognize different epitopes, since one scFv also crossreacted with the ENTH domain of the Xenopus laevis MP90 protein [40] . When the scFv-AP fusion proteins were evaluated in Western blots, only the second scFv recognized the human enthoprotin ENTH domain in blots, suggesting that it may recognize a linear epitope, while the first scFv recognizes a conformational epitope of the human enthoprotin ENTH domain.
CONCLUSION
The development of cost-effective and efficient highthroughput methods for screening and identifying affinity reagents from phage-displayed libraries is critical for increasing demands of affinity reagents for proteomics research and clinical development. A vector utilizing LIC Fig. (6) . AP fusion proteins for evaluation by ELBA and Western blotting. Crude cell lysates were used for specificity evaluation of the two selected scFvs (#1 and #2) by ELBA (A) and Western blotting (B). Two hundred nanograms of GST fusions with ENTH domain from different animal species were used for coating plates. After incubating with an equal amount of cell lysates, AP activity retained in the well was monitored with a chromogenic substrate; values shown are averages of triplicate experiments. For the Western blots, 500 ng of GST (lane 1), GST-ENTH/human (lane 2), GST-ENTH/frog (lane 3) and GST-ENTH/rat (lane 4) were resolved by SDS-PAGE. After electrophoresis, the proteins were transferred onto a nitrocellulose membrane. Crude cell lysates containing scFv-AP fusion was incubated with the blocked membrane by 10% fat-free milk, at room temperature for 1 hour. After the membrane was washed with PBST, BCIP was used as substrate to visualize the protein bands (arrow) bound by the scFv-AP fusion. The electrophoretic migrations of molecular weight standards (lane M) are listed in kilodaltons (kD).
was constructed to facilitate the transfer of phage-display DNA inserts and generation of AP fusion proteins, and one protocol was developed and successfully applied for the parallel processing of output from displayed scFv, FN3 and combinatorial peptide libraries. Compared with standard procedures that are commonly employed, this protocol eliminates several days from the screening and identification process, and once "binders" are selected, the reagents are immediately available for the functional assessment of target proteins by ELBA, Western blotting, and histochemical localization. Each step in this protocol is amenable to automation with liquid handling robots [41] , thereby facilitating high-throughput screening of affinity reagents. 
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